<DOC>
	<DOCNO>NCT03033277</DOCNO>
	<brief_summary>There high incidence woman suffer Primary Ovarian Insufficiency ( POI ) . One common treatment POI hormone replacement therapy ( HRT ) , HRT n't work well , show increase risk blood clot vein , ovarian cancer , breast cancer . The ability MSCs differentiate oocyte-like cell previously document . Herein purpose work evaluate therapeutic potential cell therapy woman suffer POI .</brief_summary>
	<brief_title>Human Umbilical Cord Mesenchymal Stem Cells ( HUC-MSCs ) Transplantation Women With Primary Ovarian Insufficiency ( POI )</brief_title>
	<detailed_description />
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<criteria>1 . Diagnosed primary ovarian insufficiency ; 2 . Women 20 40 year ; 3 . Have fertility requirement , husband sperm ; 4 . Willing sign Informed Consent Form . 1 . Primary amenorrhea ; 2 . Abnormal karyotyping ( e.g . turner syndrome , fragile X syndrome ) ; 3 . Thyroid dysfunction ; 4 . Severe endometriosis ; 5 . Contraindications pregnancy ; 6 . Prior personal history ovarian cancer ; 7 . Unwilling comply followup schedule want take treatment followup period ; 8 . History serious drug allergy allergic constitution ; 9 . Autoimmune disease , history severe familial genetic disease ; 10 . HIV+ , hepatitis B , C ;</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>